Itanapraced (CHF5074) (Synonyms: CS 1103, CSP1103, Itanapraced) |
Catalog No.GC30954 |
Itanapraced(CHF5074)(CHF5074)는 새로운 γ, Aβ,42 및 A&7#946,7,88946,7,8,8,8,8의 IC50으로 각각 분비를 감소시키는 γ-세크레타제 조절제입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 749269-83-8
Sample solution is provided at 25 µL, 10mM.
Itanapraced (CHF5074) is a novel γ-secretase modulator, reduces Aβ42 and Aβ40 secretion, with an IC50 of 3.6 and 18.4 μM, respectively.
[1]. Imbimbo BP, et al. 1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretasemodulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease withoutcausing peripheral toxicity. J Pharmacol Exp Ther. 2007 Dec;323(3):822-830. [2]. Mango D, et al. Electrophysiological and metabolic effects of CHF5074 in the hippocampus: protection against in vitro ischemia. Pharmacol Res. 2014 Mar;81:83-90.
Average Rating: 5
(Based on Reviews and 40 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *